Introduction
It has been shown that tiny portions of corneal tissue can be accurately removed by photorefractive keratectomy (PRK), apparently without causing any complications, therefore being regarded as an effective and safe method for the correction of low-to-moderate refractive errors. 1 One of the most common complications following PRK is the loss of corneal transparency secondary to corneal wound healing, which has been clinically observed as subepithelial reticular opacities, and commonly referred to as haze. [2] [3] [4] Haze after PRK tends to be maximum at 1-6 months after treatment with progressive resolution up to 18 months after surgery, 5 although it can be followed by myopic regression. 6, 7 Some investigators have reported haze with a late onset after PRK, which has been noticed in a small number of individuals usually starting between 4 months and 1 year after PRK. 2, 8 Factors unrelated to surgery, such as ultraviolet light exposure, pre-existing corneal surface disorders, and oral contraceptive use have been implicated in more severe haze and regression. 7 Although several types of ocular trauma in patients undergoing PRK can be related to the development of central cornea opacification, 9 including viral keratoconjunctivitis, this outcome is not always seen.
In this study, we report three cases of patients undergoing PRK who presented with adenoviral keratoconjunctivitis in the postoperative period and developed only subepithelial opacities, typical of this pathology, without haze or myopic regression.
Case reports
All patients underwent PRK using a VISX 20/20 excimer laser (VISX, Santa Clara, CA, USA) after mechanical de-epithelization of the cornea, with total correction of refraction under cycloplegia within a treatment zone of 6 mm in diameter. 
CASE SERIES
Each eye reepithelized within 4 days after surgery. Postoperatively they received soft bandage contact lenses until complete healing, tobramycin and dexamethasone drops q.i.d. for 7 days, followed by topical 1% predinisolone acetate q.i.d. for another 7 days, at which time 0.1% fluorometholone drops were initiated q.i.d. with gradual withdrawal during 10 weeks.
Case 1
A 27-year-old man without any pathological background, except for refractive error, underwent simultaneous bilateral refractive surgery with no complications. Preoperative cyclopegic refractions were À4.25 À1.00 Â 301 in the right eye (OD) and À4.75 À0.50 Â 1751 in the left eye (OS). Best spectacle-corrected visual acuity (VA) was 20/20 in both eyes (BE). Central pachometry was 514 mm OD and 512 mm OS.
At 3 months after surgery, the patient's VA without correction (VA w/c ) was 20/20 OD and 20/30 OS, with mild haze in OE. At that time, the patient presented with adenoviral keratoconjunctivitis and was prescribed topical dexamethasone q.i. 
Discussion
Adenovirus is one of the most frequent etiologies of keratoconjunctivitis with an acute onset. 2 Classic Figure 1 Photograph of right eye of patient 3 showing punctate epithelial keratitis staining with fluorescein.
adenovirus keratitis presents with subepithelial corneal infiltrates, which develop 1-2 weeks after acute follicular conjunctivitis and associated punctate epithelial keratitis. 10 Although other viruses can produce subepithelial infiltrates with a similar picture and cannot be ruled out, 2 our three patientsFon clinical grounds Fmost certainly had adenoviral keratoconjunctivitis.
The subepithelial infiltrates resulting from adenoviral keratoconjunctivitis are thought to represent a delayed hypersensitivity immune response to viral antigens in the corneal stroma. 11 The infiltrates are corticosteroidsensitive and often resolve in weeks to months after initial presentation. 12 It appears that the direct contact between epithelial cells and corneal stroma triggers abnormal corneal wound healing after PRK. 3, 13 Hyperactive keratocytes or loss of Bowman's layer 2 may explain the unusual response after adenoviral keratoconjunctivitis in these patients. Campos et al 9 and Pineda and Talamo 2 reported cases of patients who had undergone PRK and presented with late-onset corneal haze following adenoviral keratoconjunctivitis. In agreement with Pineda and Talamo, 2 patients who undergo PRK may be at greater risk for loss of VA following viral keratoconjunctivitis, due to secondary changes such as persistent subepithelial scarring, anterior stromal fibrosis within the PRK treatment zone, irregular corneal topographic changes, or myopic regression, all of which could influence final visual outcome.
Our three cases developed only subepithelial infiltrates, which did not respond clinically to topical corticosteroids, unlike in classic cases of adenoviral keratoconjunctivitis, in agreement with findings by Pineda and Talamo. 2 However, late-onset corneal haze, myopic regression, impairment of VA, and irregular corneal topographic changes were not observed in these patients. They presented with final VA without correction greater than or equal to 20/30.
The post-PRK inflammatory event responsible for the potentiation of the corneal response is probably related to an unknown mechanism, which can present different clinical changes in each case. Although patients undergoing PRK might develop severe corneal scarring following ocular infections, such events may follow their natural course. 
